SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Manal Salah-Eldin, Nashwa Khairat Abousamra, Hanan Azzam, Clinical significance of minimal residual disease in young adults with standard-risk/Ph-negative precursor B-acute lymphoblastic leukemia: results of prospective study, Medical Oncology, 2014, 31, 5

    CrossRef

  2. 2
    M Eefting, C J M Halkes, L C de Wreede, C M van Pelt, S Kersting, E W A Marijt, P A von dem Borne, R Willemze, H Veelken, J H F Falkenburg, Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL, Bone Marrow Transplantation, 2014, 49, 2, 287

    CrossRef

  3. 3
    Chen-Hua Yan, Qian Jiang, Jing Wang, Lan-Ping Xu, Dai-Hong Liu, Hao Jiang, Huan Chen, Xiao-hui Zhang, Kai-yan Liu, Xiao-Jun Huang, Superior Survival of Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Compared with Chemotherapy Alone Used as Post-Remission Therapy in Adults with Standard-Risk Acute Lymphoblastic Leukemia in First Complete Remission, Biology of Blood and Marrow Transplantation, 2014, 20, 9, 1314

    CrossRef

  4. 4
    Andrea Messori, Valeria Fadda, Dario Maratea, Sabrina Trippoli, Acute lymphoblastic leukemia in first complete remission: temporal trend of outcomes in studies comparing allogeneic transplant with autologous transplant or chemotherapy, Annals of Hematology, 2013, 92, 9, 1221

    CrossRef

  5. 5
    V. Gupta, S. Richards, J. Rowe, Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis, Blood, 2013, 121, 2, 339

    CrossRef

  6. 6
    Joachim Köchling, Manuel Schmidt, Yvonne Rott, Michael Sagner, Hendrik Ungefroren, Burghard Wittig, Günter Henze, Can anthocyanins improve maintenance therapy of Ph+ acute lymphoblastic leukaemia?, European Journal of Haematology, 2013, 90, 4
  7. 7
    Yanmin Zhao, He Huang, Guoqing Wei, Novel agents and biomarkers for acute lymphoid leukemia, Journal of Hematology & Oncology, 2013, 6, 1, 40

    CrossRef

  8. 8
    T Matsumura, M Kami, T Yamaguchi, K Yuji, E Kusumi, S Taniguchi, S Takahashi, M Okada, H Sakamaki, H Azuma, M Takanashi, H Kodo, S Kai, T Inoue-Nagamura, K Kato, S Kato, Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan, Leukemia, 2012, 26, 7, 1482

    CrossRef

  9. 9
    Mohammad Bakr, Walid Rasheed, Said Y. Mohamed, Fahad Al-Mohareb, Naeem Chaudhri, Fahad Al-Sharif, Hazza Al-Zahrani, Ghuzayel Al-Dawsari, Abu Jafar Saleh, Amr Nassar, Shad Ahmed, Assem Elghazaly, Syed O. Ahmed, Khalid Ibrahim, Wahiba Chebbo, Ghada M. El Gohary, Muhamad H. Al Mahayni, Fazal Hussain, Zubeir Nurgat, Tusneem Ahmed Elhassan, Claudia U. Walter, Mahmoud Aljurf, Allogeneic Hematopoietic Stem Cell Transplantation in Adolescent and Adult Patients with High-Risk T Cell Acute Lymphoblastic Leukemia, Biology of Blood and Marrow Transplantation, 2012, 18, 12, 1897

    CrossRef

  10. 10
    Weerapong Prasongchean, Patrizia Ferretti, Autologous stem cells for personalised medicine, New Biotechnology, 2012, 29, 6, 641

    CrossRef

  11. 11
    Brian L Burnette, Mrinal S Patnaik, Mark R Litzow, Pharmacotherapy for adult acute lymphoblastic leukemia: an update from recent clinical trials and future directions, Clinical Investigation, 2012, 2, 7, 715

    CrossRef

  12. 12
    T. Azuma, K. Tobinai, K. Takeyama, T. Shibata, M. Hidaka, M. Kurosawa, M. Kasai, T. Chou, N. Fukushima, K. Mukai, K. Tsukasaki, M. Shimoyama, Phase II Study of Intensive Post-remission Chemotherapy and Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Japan Clinical Oncology Group Study, JCOG9402, Japanese Journal of Clinical Oncology, 2012, 42, 5, 394

    CrossRef

  13. 13
    Joachim Köchling, Yvonne Rott, Stefanie Arndt, Christina Marschke, Manuel Schmidt, Burghardt Wittig, Katrin Kalies, Jürgen Westermann, Günter Henze, Prevention and synergistic control of Ph+ ALL by a DNA vaccine and 6-mercaptopurine, Vaccine, 2012, 30, 41, 5949

    CrossRef

  14. 14
    Denise M. Oliansky, Richard A. Larson, Daniel Weisdorf, Hildy Dillon, Thomas A. Ratko, Donna Wall, Philip L. McCarthy, Theresa Hahn, The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review, Biology of Blood and Marrow Transplantation, 2012, 18, 1, 18

    CrossRef

  15. 15
    Frederick R. Appelbaum, Goldman's Cecil Medicine, 2012,

    CrossRef

  16. 16
    Julie M. Vose, Goldman's Cecil Medicine, 2012,

    CrossRef

  17. 17
    Josep-Maria Ribera, Advances in acute lymphoblastic leukemia in adults, Current Opinion in Oncology, 2011, 23, 6, 692

    CrossRef

  18. 18
    Rob Sellar, Anthony H. Goldstone, Hillard M. Lazarus, Redefining Transplant in Acute Leukemia, Current Treatment Options in Oncology, 2011, 12, 4, 312

    CrossRef

  19. 19
    K. Paulson, D. Szwajcer, M.D. Seftel, The role of allogeneic stem cell transplantation for adult acute lymphoblastic leukemia, Transfusion and Apheresis Science, 2011, 44, 2, 197

    CrossRef

  20. 20
    Rob S. Sellar, Anthony H. Goldstone, Transplants for the Old But Not for the Young?—The Enigma of Adult ALL, Biology of Blood and Marrow Transplantation, 2011, 17, 1, S71

    CrossRef

  21. 21
    Joseph Pidala, Benjamin Djulbegovic, Claudio Anasetti, Mohamed Kharfan-Dabaja, Ambuj Kumar, Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission, The Cochrane Library,